
CBIO
Catalyst Biosciences Inc
$13.11
+$0.19(+1.47%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$173.66M
Volume
155.06K
52W Range
$10.83 - $21.40
Target Price
$25.60
Order:
Income Statement
Metric | Trend | Chart | 2014 Dec | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||
Total Revenue | $15.0M | $20.1M | $18.5K | -- | -- | -- | $10.2M | $1.2M | $75.0K | ||
Total Revenue | $15.0M | $20.1M | $18.5K | -- | -- | -- | $10.2M | $1.2M | $75.0K | ||
GROSS PROFIT | |||||||||||
Gross Profit | $15.0M | $20.1M | $18.5K | -- | -- | -- | $10.2M | $1.2M | $75.0K | ||
OPERATING EXPENSES | |||||||||||
Operating Expenses | $-26.2M | $-32.9M | $-31.9M | $-33.9M | $-51.5M | $61.4M | $61.7M | $64.6M | $47.5M | ||
Research & Development | $19.6M | $25.1M | $23.3M | $24.1M | $40.1M | $47.0M | $44.9M | $47.5M | $28.4M | ||
Research Expense | $19.6M | $25.1M | $23.3M | $24.1M | $40.1M | $47.0M | $44.9M | $47.5M | $28.4M | ||
Selling, General & Administrative | $6.6M | $7.8M | $8.7M | $9.8M | $11.4M | $14.4M | $16.7M | $17.1M | $19.1M | ||
Selling & Marketing Expenses | $6.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
General & Administrative Expenses | $6.6M | $7.8M | $8.7M | $9.8M | $11.4M | $14.4M | $16.7M | $17.1M | $19.1M | ||
Salaries & Wages | $-1.6M | $-2.3M | $-3.0M | $-3.8M | $-4.6M | -- | -- | -- | -- | ||
Depreciation & Amortization | $-158.7K | $-191.5K | $-190.5K | $-263.5K | $-275.1K | $279.2K | $270.8K | $264.6K | $207.1K | ||
Depreciation & Amortization | $-158.7K | $-191.5K | $-190.5K | $-263.5K | $-275.1K | $279.2K | $270.8K | $264.6K | $207.1K | ||
Other Operating Expenses | -- | -- | -- | -- | -- | $1.4M | $1.5B | $1.4M | $1.5M | ||
OPERATING INCOME | |||||||||||
Operating income | $-11.1M | $-12.8M | $-31.9M | $-33.9M | $-51.5M | $-61.4M | $-51.5M | $-63.4M | $-47.4M | ||
EBITDA | $-11.0M | $-12.6M | $-31.6M | $-33.0M | $-48.0M | $-57.0M | $-51.2M | $-63.2M | $-47.2M | ||
NON-OPERATING ITEMS | |||||||||||
Intinc | -- | -- | -- | $651.2K | $3.2M | $3.5M | $482.5K | $19.8K | $714.5K | ||
Net Non-Operating Interest Income/Expense | -- | -- | -- | $651.2K | $3.2M | $3.5M | $482.5K | $19.8K | $714.5K | ||
Other Income/Expense | $-18.2K | $-15.3K | $-103.6K | $-651.2K | -- | -- | -- | -- | -- | ||
Other Special Charges | $18.2K | $15.3K | $103.6K | $651.2K | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | |||||||||||
EBIT | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.5M | $-63.4M | $-47.4M | ||
Pre-Tax Income | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.0M | $-63.4M | $-46.7M | ||
NET INCOME | |||||||||||
Net Income | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.0M | $-63.4M | $-46.7M | ||
Net Income (Continuing Operations) | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.0M | $-63.4M | $-46.7M | ||
Net Income (Discontinued Operations) | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.0M | $-63.4M | $-46.7M | ||
Net Income (Common Stockholders) | $-11.1M | $-12.8M | $-31.8M | $-33.3M | $-48.3M | $-57.9M | $-51.0M | $-63.4M | $-46.7M | ||
TOTALS | |||||||||||
Total Expenses | $-26.2M | $-32.9M | $-31.9M | $-33.9M | $-51.5M | $61.4M | $61.7M | $64.6M | $47.5M | ||
SHARE & EPS DATA | |||||||||||
Shares Outstanding | $19.0M | $19.1M | $23.3M | $34.4M | $13.9M | $13.9M | $51.5M | $52.3M | $64.2M | ||
OTHER METRICS | |||||||||||
Other Gand A | $6.6M | $7.8M | $8.7M | $9.8M | $11.4M | $14.4M | $16.7M | $17.1M | $19.1M | ||
Rent And Landing Fees | $6.6M | $7.8M | $8.7M | $9.8M | $11.4M | -- | -- | -- | -- | ||
Selling Expense | $6.6M | -- | -- | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | CBIO | $13.11 | +1.5% | 155.06K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Catalyst Biosciences Inc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW